SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Aerie Pharmaceuticals, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of June 29, 2015 -- AERI
(firmenpresse) - NEW YORK, NY -- (Marketwired) -- 05/08/15 -- The following statement is being issued by Levi & Korsinsky, LLP:
(NASDAQ: AERI)
that a securities class action lawsuit has been commenced in the United States District Court for the District of New Jersey. If you purchased or otherwise acquired Aerie Pharmaceuticals, Inc. ("Aerie Pharmaceuticals") securities between August 6, 2014 and April 23, 2015, . To get more information :
or contact Joseph E. Levi, Esq. either via email at or by telephone at (212) 363-7500, toll-free: (877) 363-5972.
The complaint alleges that during the Class Period, Aerie Pharmaceuticals made false and misleading statements and/or failed to disclose adverse information regarding the Company's prospects for Rhopressa.
On April 23, 2015, Aerie Pharmaceuticals issued a release announcing that Rhopressa did not meet its "primary efficacy endpoint" in its first Phase 3 registration trial. Upon this news, shares of Aerie Pharmaceuticals fell more than 60 percent to close at $12.87 per share on April 24, 2015.
to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 08.05.2015 - 17:48 Uhr
Sprache: Deutsch
News-ID 391978
Anzahl Zeichen: 0
contact information:
Town:
NEW YORK, NY
Kategorie:
Legal
Diese Pressemitteilung wurde bisher 202 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Aerie Pharmaceuticals, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of June 29, 2015 -- AERI"
steht unter der journalistisch-redaktionellen Verantwortung von
Levi & Korsinsky, LLP (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
